Company Filing History:
Years Active: 2010
Title: Yizhuang Xu: Innovator in Non-Invasive Tissue Detection
Introduction
Yizhuang Xu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical diagnostics through his innovative approach to detecting changes in organism tissues. His work focuses on non-invasive methods that enhance patient comfort while providing accurate diagnostic results.
Latest Patents
Yizhuang Xu holds a patent for a non-invasive method and apparatus for the detection of organism tissues. This invention relates to diagnosing changes in molecular structures of organism tissues from the body surface using a dedicated apparatus. The apparatus includes a Fourier Transform infrared spectrometer and various accessories, such as a mid-IR fiber optics sampling attachment, a fiber coupling part, and an infrared detector part. The detection method involves placing the ATR probe on the skin surface of the area to be tested and scanning multiple times. The apparatus operates with a resolution of 1-32 cm and a spectrum range of 800-4000 cm. This method allows for the early detection of molecular changes in living biological tissues, particularly in the early stages of cancer, without causing discomfort to the test subjects. The process is designed to be easy to operate, quick, and accurate, ensuring that it does not harm the body.
Career Highlights
Throughout his career, Yizhuang Xu has worked with notable institutions, including Peking University and Beijing Second Optical Instrument Factory. His experience in these organizations has contributed to his expertise in the field of optical instruments and medical diagnostics.
Collaborations
Yizhuang Xu has collaborated with esteemed colleagues, including Jinguang Wu and Yuanfu Zhang. Their combined efforts have further advanced the research and development of non-invasive diagnostic technologies.
Conclusion
Yizhuang Xu's innovative work in non-invasive tissue detection represents a significant advancement in medical diagnostics. His contributions not only enhance the accuracy of early cancer detection but also prioritize patient comfort. His ongoing research and collaborations continue to pave the way for future innovations in this critical field.